Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-18

Clinical Trial Update: Progesterone Supplementation in Threatened Abortion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on progesterone supplementation for threatened abortion with progesterone resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tanta University | Conditions: Threatened Abortion, Progesterone Resistance | Phase 4 | Status: COMPLETED